Indeed, we have established that these three inhibitors block the shedding of ADAM-17 targets such as TNFα, TGFα and amphiregulin (AREG) with the same efficacy (data not shown) whereas TMI-2 and TMI-005 only partially inhibit tumor cell growth and do not induce apoptosis. Here, TGFA is linked to neoplasm.